Lexeo Therapeutics Launches Public Offering and Private Placement with Balyasny Asset Management
Lexeo Therapeutics has launched an underwritten public offering and a concurrent private placement of its common stock and pre-funded warrants. The private placement involves Balyasny Asset Management, with the size and timing of both offerings dependent on market conditions.
The public offering and private placement are not contingent on each other, as per Lexeo Therapeutics. The company aims to sell shares to the public and additional shares and warrants to Balyasny Asset Management, exempt from SEC registration. Details about the investment manager involved in the private placement are not currently available, and such information is typically sourced from specialized financial news outlets or press releases from the involved companies.
Lexeo Therapeutics is proceeding with its public offering and private placement, with the latter involving Balyasny Asset Management. Market conditions will dictate the size and timing of these offerings. Further details on the private placement may be found through specialized financial news sources or press releases from the company.
